MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-KL-14-0002045
White Line Pharma Private Limited
White Line Pharma Private Limited - pharma in Kalpetta, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹25.07 Cr
▲ 12% YoY
Net profit · FY 2025
₹30 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹1.13 Cr
EBITDA margin 4.5%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹75 Lakh
Issued & subscribed
Open charges
₹3.64 Cr
Satisfied ₹3.95 Cr
Company age
25 yrs
Est. 2001
Directors on board
3
As per MCA filings
About White Line Pharma Private Limited
Data last updated:
White Line Pharma Private Limited is a private limited company based in Kalpetta, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 December 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24231KL2001PTC015134. Its GSTIN is 32AAACW4234F1ZR (Kerala).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It is led by directors including Aramangalam Krishnan Chetty Ramakrishnan (Managing Director) and Kizhakke Puthankandi Muhammad Sharmil.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Door No.Xiii/897(3) Sakthi Arcade Leo Hospital Road Vythiri Taluk, Kalpetta, Kerala, India – 673121.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.07 Cr, a growth of 12% compared to the previous year. For the same year it recorded a net profit of ₹30 Lakh (net margin 1.2%) and EBITDA of ₹1.13 Cr (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 13% over five years.
As per MCA filings, the company has open charges of ₹3.64 Cr and satisfied charges of ₹3.95 Cr on record.
White Line Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-14-0002045). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24231KL2001PTC015134
Registration Number 015134
Incorporation Date 21 December 2001
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-14-0002045
Key People
Aramangalam Krishnan Chetty Ramakrishnan Managing Director Kizhakke Puthankandi Muhammad Sharmil Director Cholangady Kalappan Vinod Director Recognitions & Rankings of White Line Pharma
Contact details
White Line Pharma Private Limited's registered office is in Kalpetta, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDoor No.Xiii/897(3) Sakthi Arcade Leo Hospital Road Vythiri Taluk, Kalpetta, Kerala, India – 673121
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of White Line Pharma Private Limited, buy the company report.
Comprehensive company report
White Line Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of White Line Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of White Line Pharma Private Limited, buy the company report.
Financials of White Line Pharma Private Limited
FY 2025 filings availableWhite Line Pharma Private Limited reported revenue of ₹25.07 Cr (up 12% YoY) for FY 2025.
Revenue · FY 2025
₹25.07 Cr ▲ 12%
Net profit · FY 2025
₹30 Lakh margin 1.2%
EBITDA · FY 2025
₹1.13 Cr margin 4.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 12%
3 years · compounded
▲ 20%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 18%
5 years · compounded
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 12% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.13 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.5% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of White Line Pharma Private Limited, buy the company report.
Board of directors of White Line Pharma Private Limited
White Line Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kizhakke Puthankandi Muhammad Sharmil Also directs: Wayanad Lake Resort LLP | Director | 31 Dec 2019 | 6 Years 10 Months | Current |
| Aramangalam Krishnan Chetty Ramakrishnan Also directs: Wayanad Lake Resort LLP | Managing Director | 21 Dec 2001 | 24 Years 10 Months | Current |
| Cholangady Kalappan Vinod | Director | 21 Dec 2001 | 24 Years 10 Months | Current |
Peer comparison
White Line Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rainbow Life Sciences Private Limited | ₹25.18 Cr (FY 2025) | -12.0% | Navi Mumbai, Maharashtra, India | |||
| Vanchinad Pharma Private Limited | ₹25.1 Cr (FY 2025) | 22.0% | Kottayam, Kerala, India | |||
| White Line Pharma Private Limitedthis company | ₹25.07 Cr (FY 2025) | ₹30 Lakh | 1.2% | 12.0% | Kalpetta, Kerala, India | |
| Comship Medix and Infra Private Limited | ₹25.05 Cr (FY 2022) | 1092.0% | Patna, Bihar, India | |||
| SD Jain Pharmaceuticals Private Limited | ₹25 Cr (FY 2024) | 4.0% | Chennai, Tamil Nadu, India | |||
| Sentosa Geigy (India) Labs Limited | ₹24.79 Cr (FY 2025) | 50.0% | Delhi, India |
To see the full peer comparison of White Line Pharma Private Limited, buy the company report.
Auditor
White Line Pharma Private Limited is audited by T.P. PAUL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T.P. PAUL & ASSOCIATES | FY 2023 | 006109S |
Shareholding
The shareholding of White Line Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of White Line Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.64 Cr
Satisfied charges
₹3.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Jan 2022 | 100530163 | Others | ₹21 Lakh | Open | |
| 10 Jun 2020 | 100345305 | Others | ₹42.68 Lakh | Open | |
| 02 Aug 2017 | 100120512 | Others | ₹3 Cr | Open | |
| 13 Mar 2013 | 10412834 | State Bank of Travancore | ₹1.95 Cr | Satisfied | |
| 17 May 2012 | 10359383 | Vijaya Bank | ₹75 Lakh | Satisfied |
To see the full charge records of White Line Pharma Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
No court or tribunal cases involving White Line Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for White Line Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
White Line Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAACW4234F1ZR | Kerala | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of White Line Pharma Private Limited, buy the company report.
Recent activity
White Line Pharma Private Limited has 4 board changes on record since 2001: 3 appointments and 1 cessation. The latest: Kizhakke Puthankandi Muhammad Sharmil was appointed as Director on 31 Dec 2019.
AGM
White Line Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
White Line Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge with Others of Rs. 300.00 Lakh registered on 02 Aug 2017 with Charge ID 100120512 was modified on 18 Mar 2023.
Charges
A charge with Others amounted to Rs. 21.00 Lakh with Charge ID 100530163 was registered on 24 Jan 2022.
Charges
A charge with Others amounted to Rs. 42.68 Lakh with Charge ID 100345305 was registered on 10 Jun 2020.
Appointed
Kizhakke Puthankandi Muhammad Sharmil was appointed as Director.
Charges
A charge registered on 13 Mar 2013 via Charge ID 10412834 with State Bank Of Travancore was fully satisfied on 27 Sep 2017.
Charges
A charge with Others amounted to Rs. 300.00 Lakh with Charge ID 100120512 was registered on 02 Aug 2017.
Ceased
Kunhimoideen ceased to be Director.
Charges
A charge with State Bank Of Travancore of Rs. 195.00 Lakh registered on 13 Mar 2013 with Charge ID 10412834 was modified on 15 Jun 2016.
Charges
A charge with State Bank Of Travancore amounted to Rs. 195.00 Lakh with Charge ID 10412834 was registered on 13 Mar 2013.
Charges
A charge registered on 17 May 2012 via Charge ID 10359383 with Vijaya Bank was fully satisfied on 13 Mar 2013.
11 earlier events are in the company report.
Frequently asked questions
White Line Pharma is an active private limited company based in Kalpetta, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 December 2001 (25+ years old) and is registered under CIN U24231KL2001PTC015134.
White Line Pharma has 3 current directors:
- Aramangalam Krishnan Chetty Ramakrishnan - Managing Director
- Kizhakke Puthankandi Muhammad Sharmil - Director
- Cholangady Kalappan Vinod - Director
The latest financial statements of White Line Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of White Line Pharma is 32AAACW4234F1ZR, registered in Kerala.
The CIN (Corporate Identification Number) of White Line Pharma is U24231KL2001PTC015134. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
White Line Pharma was incorporated on 21 December 2001, making it 25+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of White Line Pharma by revenue are Rainbow Life Sciences Private Limited, Vanchinad Pharma Private Limited, Comship Medix and Infra Private Limited, SD Jain Pharmaceuticals Private Limited, Sentosa Geigy (India) Labs Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kizhakke Puthankandi Muhammad Sharmil was appointed as Director on 31 Dec 2019. Kunhimoideen ceased to be Director on 15 Oct 2016. Aramangalam Krishnan Chetty Ramakrishnan was appointed as Managing Director on 21 Dec 2001. White Line Pharma has 4 board changes on record in total.
Yes, White Line Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KL-14-0002045).
The registered office of White Line Pharma is at Door No.Xiii8973 Sakthi Arcade Leo Hospital Road Vythiri Taluk, Kalpetta, Kerala, India – 673121.
White Line Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages